Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385269079> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- W4385269079 endingPage "e92" @default.
- W4385269079 startingPage "e91" @default.
- W4385269079 abstract "Enfortumab vedotin-ejfv (Padcev – Astellas), a nectin-4-directed antibody and microtubule inhibitor conjugate, has received accelerated approval from the FDA for use with the immune checkpoint inhibitor pembrolizumab (Keytruda) for treatment of locally advanced or metastatic urothelial cancer in adults who are ineligible for cisplatin-containing chemotherapy." @default.
- W4385269079 created "2023-07-27" @default.
- W4385269079 date "2023-05-29" @default.
- W4385269079 modified "2023-10-04" @default.
- W4385269079 title "Enfortumab Vedotin (Padcev) for Urothelial Cancer" @default.
- W4385269079 doi "https://doi.org/10.58347/tml.2023.1677g" @default.
- W4385269079 hasPublicationYear "2023" @default.
- W4385269079 type Work @default.
- W4385269079 citedByCount "0" @default.
- W4385269079 crossrefType "journal-article" @default.
- W4385269079 hasBestOaLocation W43852690791 @default.
- W4385269079 hasConcept C121608353 @default.
- W4385269079 hasConcept C126322002 @default.
- W4385269079 hasConcept C143998085 @default.
- W4385269079 hasConcept C2776694085 @default.
- W4385269079 hasConcept C2777701055 @default.
- W4385269079 hasConcept C2778239845 @default.
- W4385269079 hasConcept C2780057760 @default.
- W4385269079 hasConcept C2780352672 @default.
- W4385269079 hasConcept C3020745361 @default.
- W4385269079 hasConcept C502942594 @default.
- W4385269079 hasConcept C71924100 @default.
- W4385269079 hasConceptScore W4385269079C121608353 @default.
- W4385269079 hasConceptScore W4385269079C126322002 @default.
- W4385269079 hasConceptScore W4385269079C143998085 @default.
- W4385269079 hasConceptScore W4385269079C2776694085 @default.
- W4385269079 hasConceptScore W4385269079C2777701055 @default.
- W4385269079 hasConceptScore W4385269079C2778239845 @default.
- W4385269079 hasConceptScore W4385269079C2780057760 @default.
- W4385269079 hasConceptScore W4385269079C2780352672 @default.
- W4385269079 hasConceptScore W4385269079C3020745361 @default.
- W4385269079 hasConceptScore W4385269079C502942594 @default.
- W4385269079 hasConceptScore W4385269079C71924100 @default.
- W4385269079 hasIssue "1677" @default.
- W4385269079 hasLocation W43852690791 @default.
- W4385269079 hasOpenAccess W4385269079 @default.
- W4385269079 hasPrimaryLocation W43852690791 @default.
- W4385269079 hasRelatedWork W2796582438 @default.
- W4385269079 hasRelatedWork W2892640821 @default.
- W4385269079 hasRelatedWork W2948845624 @default.
- W4385269079 hasRelatedWork W2969782175 @default.
- W4385269079 hasRelatedWork W3215044659 @default.
- W4385269079 hasRelatedWork W363598932 @default.
- W4385269079 hasRelatedWork W4206600817 @default.
- W4385269079 hasRelatedWork W4235080808 @default.
- W4385269079 hasRelatedWork W4247922271 @default.
- W4385269079 hasRelatedWork W4255240967 @default.
- W4385269079 hasVolume "65" @default.
- W4385269079 isParatext "false" @default.
- W4385269079 isRetracted "false" @default.
- W4385269079 workType "article" @default.